This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
AML - 1587
Acute Myeloid Leukemia (AML)
AIM: To evaluate the effect of FLT3 inhibitor maintenance after allogeneic hematopoietic stem cell transplantation on Relapse Free Survival (RFS) and Overall Survival (OS) using reconstructed individual patient data from randomized controlled trials involving adults with FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) acute myeloid leukemia (AML).